Form 4: Hartford EVP Lori Rodden Acquires RSUs, Options
Insider Transaction Report
Hartford Insurance Group Executive Vice President Lori A. Rodden reported the acquisition of Restricted Stock Units and stock options, alongside a disposition of common stock.
Summary
- Lori A. Rodden, Executive Vice President of Hartford Insurance Group, Inc. (HIG), reported transactions on February 24, 2026.
- Acquired 8,894.265 Restricted Stock Units (RSUs) at a price of $140.54 per unit.
- Disposed of 25,391.617 shares of Common Stock.
- Acquired 9,136 stock options with an exercise price of $140.54, expiring on February 24, 2036. These options will vest in three equal annual installments starting February 24, 2027.
- Beneficially owns additional stock options with various exercise prices and vesting schedules, including 30,193 options at $69.41, 26,079 options at $78.28, 11,399 options at $95.74, and 9,467 options at $116.41.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a routine disclosure of executive compensation and insider trading activity. The acquisition of RSUs and options is generally positive for aligning management interests, while the common stock disposition is a common occurrence for tax or liquidity purposes.
Positives
- Acquisition of 8,894.265 Restricted Stock Units (RSUs) at $140.54, indicating continued equity participation and alignment with shareholder interests.
- Grant of 9,136 stock options at an exercise price of $140.54, providing long-term incentive for the Executive Vice President.
Negatives
- Disposition of 25,391.617 shares of Common Stock, which could be for tax purposes or personal liquidity, but reduces direct share ownership.
Future Outlook
NA
Industry Context
StockSavvy.ai notes that insider transactions, such as the acquisition of equity awards and the disposition of common stock by an Executive Vice President, are common in the insurance industry as part of executive compensation packages designed to align management incentives with long-term shareholder value. The mix of RSUs and stock options reflects a standard approach to executive equity incentives.
Comparison to Industry Standards
- The compensation structure, involving both Restricted Stock Units and stock options with multi-year vesting schedules, aligns with typical executive incentive plans observed across major U.S. financial and insurance companies.
- For instance, peers like Chubb Limited (CB) or Travelers Companies (TRV) often utilize similar equity-based compensation to retain talent and incentivize performance. The specific quantities and prices are company-specific but the mechanism is standard.
Stakeholder Impact
- Shareholders: The acquisition of equity awards by an executive generally aligns management's interests with long-term shareholder value. The disposition of common stock is a routine event that may not have significant impact.
- Employees: No direct impact mentioned.
Next Steps
- First one-third of newly acquired stock options (exercise price $140.54) will become exercisable on February 24, 2027.
- Second one-third of newly acquired stock options (exercise price $140.54) will become exercisable on February 24, 2028.
- Remaining one-third of newly acquired stock options (exercise price $140.54) will become exercisable on February 24, 2029.
- Remaining one-third of stock options with exercise price $78.28 will become exercisable on February 28, 2026.
- Second one-third of stock options with exercise price $95.74 will become exercisable on February 27, 2026.
- Remaining one-third of stock options with exercise price $95.74 will become exercisable on February 27, 2027.
- Second one-third of stock options with exercise price $116.41 will become exercisable on February 25, 2027.
- Remaining one-third of stock options with exercise price $116.41 will become exercisable on February 25, 2028.
Key Dates
| Date | Description |
|---|---|
| 02/23/2022 | Implied grant date for stock options with exercise price $69.41, which became fully exercisable on February 23, 2025. |
| 02/28/2023 | Implied grant date for stock options with exercise price $78.28, with vesting installments on February 28, 2024, February 28, 2025, and February 28, 2026. |
| 02/27/2024 | Implied grant date for stock options with exercise price $95.74, with vesting installments on February 27, 2025, February 27, 2026, and February 27, 2027. |
| 02/23/2025 | Stock options with an exercise price of $69.41 became fully exercisable. |
| 02/25/2025 | Implied grant date for stock options with exercise price $116.41, with vesting installments on February 25, 2026, February 25, 2027, and February 25, 2028. |
| 02/24/2026 | Transaction date for the acquisition of Restricted Stock Units and new stock options, and the disposition of common stock. |
| 02/25/2026 | One-third of stock options with an exercise price of $116.41 became exercisable. |
| 02/26/2026 | Signature date of the reporting person's attorney-in-fact. |
| 02/27/2026 | An additional one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/28/2026 | The remaining one-third of stock options with an exercise price of $78.28 will become exercisable. |
| 02/24/2027 | The first one-third of the newly acquired stock options (exercise price $140.54) will become exercisable. |
| 02/25/2027 | An additional one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/27/2027 | The remaining one-third of stock options with an exercise price of $95.74 will become exercisable. |
| 02/24/2028 | The second one-third of the newly acquired stock options (exercise price $140.54) will become exercisable. |
| 02/25/2028 | The remaining one-third of stock options with an exercise price of $116.41 will become exercisable. |
| 02/24/2029 | The remaining one-third of the newly acquired stock options (exercise price $140.54) will become exercisable. |
| 02/23/2032 | Expiration date for stock options with an exercise price of $69.41. |
| 02/28/2033 | Expiration date for stock options with an exercise price of $78.28. |
| 02/27/2034 | Expiration date for stock options with an exercise price of $95.74. |
| 02/25/2035 | Expiration date for stock options with an exercise price of $116.41. |
| 02/24/2036 | Expiration date for the newly acquired stock options with an exercise price of $140.54. |
Recommendation
holdThis Form 4 filing details routine executive compensation in the form of Restricted Stock Units and stock options, alongside a disposition of common stock. While the acquisition of equity awards generally aligns management incentives with shareholder interests, the disposition is a common occurrence for tax or liquidity planning and does not signal a change in company fundamentals or strategic direction. Therefore, the filing itself does not provide new information warranting a change in investment thesis, suggesting a 'hold' recommendation.
Keywords
Hartford Insurance Group, HIG, Lori A Rodden, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Executive Compensation, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.